Fulcrum Therapeutics, Inc. Announces Retirement of Alan Musso as Chief Financial Officer

Published: 2026-04-27 08:50:30 ET FULC

Published on 04/27/2026 at 08:50 am EDT

Fulcrum Therapeutics, Inc. announced that Chief Financial Officer, Alan Musso plans to retire later this year to spend more time with his family and other outside interests. Mr. Musso will remain in his role until a successor is named and has agreed to serve as a consultant thereafter to support a seamless transition. Fulcrum will initiate a search to identify a successor.